Advanced search
Publication Cover
Hematology Volume 8, 2003 - Issue 6
Submit an article Journal homepage
160
Views
0
CrossRef citations to date
0
Altmetric
Articles

Lamivudine Therapy in Acute Leukemia Patients who are Hepatitis B Surface Antigen Carriers

Mehmet YilmazDepartment of Hematology, Ankara Numune Education and Research Hospital, Samanpazari 06100, Ankara, Turkey
,
Simten DagdasDepartment of Hematology, Ankara Numune Education and Research Hospital, Samanpazari 06100, Ankara, Turkey
,
Nil GülerDepartment of Hematology, Ankara Numune Education and Research Hospital, Samanpazari 06100, Ankara, Turkey
,
Sahika Zeynep AkiDepartment of Hematology, Ankara Numune Education and Research Hospital, Samanpazari 06100, Ankara, Turkey
,
Ayla Gökmen AközDepartment of Hematology, Ankara Numune Education and Research Hospital, Samanpazari 06100, Ankara, Turkey
,
Gülsüm ÖzetDepartment of Hematology, Ankara Numune Education and Research Hospital, Samanpazari 06100, Ankara, Turkey
,
Meltem AyliDepartment of Hematology, Ankara Numune Education and Research Hospital, Samanpazari 06100, Ankara, Turkey
&
Ulkü SaritasDepartment of Gastroenterology, Ankara Numune Education and Research Hospital, Samanpazari 06100, Ankara, Turkey
 show all
Pages 393-396 | Published online: 04 Sep 2013

References

  • Yenen, OS., Wilke. Topçu, A., Söyletir, G., Doganay, M., eds, (1996) Hepatit B: I nfection Disease, 1st Ed. (Nobel medical publishers, Istanbul), pp 664–691.
  • Kocaba*, E., Aksaray, N., Alhan, E., Tanyeli, A. and Köksal, F. (1997) "Hepatitis B and C virus infection in Turkish children", Fur. J. Epidemiol. 13, 869–873.
  • Lok, Anna S.F., Liang, Raymond H.S., Chm, Edmond K.W., Wong, Kee-Lam, Chan, Tai-Kwong and Todd, David (1991) "Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy", Gastroenterology 100, 182–188.
  • Xunrong, L., Yan, A.W., Liang, R. and Lau, G.K.K. (2001) "Hepatitis B virus (HBV) reactivation after cytotoxic or immunosuppressive therapy-pathogenesis and manage-ment", Rev. Med. Virol. 11, 287–299.
  • Shibolet, O., Ilan, Y., Gillis, S., Hubert, A., Shouval, D. and Safadi, R. (2002) "Lamuvidin therapy for prevention of immunosuppressive-induced hepatitis B virus reactiva-tion in hepatitis B surface antigen carriers", Blood 100(2), 391–396.
  • Silvestri, F., Ermacora, A., Sperotto, A., Patriarca, F., Zaja, F., Damiarn, D., Fanin, R. and Baccarram, M. (2000) "Lamuvidin allows completion of chemotherapy in lym-phoma patients with hepatitis B reactivatation", Br. J. Haematol. 108, 394–396.
  • Endo, T., Sakai, T., Fujimoto, K., Yamamoto, S., Takashima, H., Haseyama, Y, Nishio, M., Koizumi, K., Koike, T. and Sawada, K. (2001) "A possible role for lamuvidine as prophlaxis against hepatitis B reactivation in carriers of hepatitis B who undergo chemotherapy and auto-logous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma", Bone Marrow Trans plat. 27, 433–436.
  • Born, C., Penna, A., Ogg, G., Bertoletti, A., Pi111, M., Cavallo, C., Cava A., Urbam, S., et al. (2001) "Lamivuidine treatment can overcome cytotoxic T-cell hyporesponsiveness in Chronic Hepatotis: New perspectives for immune therapy", Hepatology 33(4), 963–971.
  • Yeo, W., Chan, P.K.S., Chan, H.L.Y., Mo, F.K.F. and Johnson, P.J. (2001) "Hepatitis B virus reactivation during cytotoxic chemotherapy-enhanced viral replication precedes overt hepatitis", J. Med. Virol. 65, 473–477.
  • Nakamura, Y, Motokura, T., Fujita, A., Yamashita, T. and Ogata, E. (1996) "Severe hepatitis related to chemotherapy in Hepatitis B virus carriers with hematologic malignancies", Cancer 78, 2210–2215.
  • Rossi, G., Pelizarri, A., Motta, M. and Puoti, M. (2001) "Primary Prophlaxis with Lamuvidine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy", Br. J. Haematol. 115, 58–62.
  • Lai, C.L., Chmg, C.K., Ming Tung, A.K., Li, E., Yong, J., Hill, A., Wong, B.C.Y., Dent, J. and Wu, P.C. (1997) "Lamuvidin is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers", Hepatology 25(1), 241–244.
  • Liaw, FY., Chien, N.R., Yeh, T.C., Tsai, S.L. and Chu, C.M. (1999) "Acute exacerbation and Hepatitis B virus clearance after emergence of YMDD motif mutation during Lamuvi-dine therapy", Hepatology 30(2), 567–572.
  • Clark, F.L., Drummond, M.W., Chambers, S., Chapman, B.A. and Patton, W.N. (1998) "Successful treatment with Lamuvi-dine for fulminant reactivated Hepatitis B infection following intensive therapy for high-grade non-Hodgin's Lymphoma", Ann. Oncol. 9, 385–387.
  • Henkes, N., Martin, S., Einsele, R. and Aulitzky, W.E. (2002) "Succeseful antiviral treatment for fulminant reactivated hepatitis B after autologous stem cell transplantation and prophlaxis during subsequent allogeneic stim cell transplan-tation", Ann. Hematol. 81(6), 343–346.
  • Carpanter, P.A., Huang, M.L. and McDonald, G.B. (2002) "Activation of occult hepatitis B from a seronegative patient after hematopoietic cell transplant", Blood 99(11), 4245–4246.
  • Henkes, M., Martin, S., Einsele, H. and Aulitzky, W.E. (2002) "Successful antiviral treatment for fulminant reactivated hepatitis B after autologous stem cell transplantation and prophylaxis during subsequent allogeneic stem cell trans-plantation", Ann. Hematol. 8, 343–346.
  • Uchida, N., Condo, H., Himeji, D., Kaji, Y, Sata, M. and Niho, Y. (2000) "Lamuvidine therapy for a hepatitis B surface antigen(HbsAg) positive leukemia patient receiving myelo-ablative chemotherapy and autologous stem cell transplan-tation", Bone Marrow Transplat. 26, 1243–1245.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.